Clincosm LogoSign in Get a demo

Blood Cancer

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Immune Profiling for Cancer Immunotherapy Response

Recruiting
  • Cancer
  • +3 more
  • Methylation Cytometry
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Nov 6, 2023

Blood Cancer, Refractory Immune Cytopenias Trial in United States (Isatuximab)

Not yet recruiting
  • Blood Cancer
  • Refractory Immune Cytopenias
  • Isatuximab
  • Basking Ridge, New Jersey
  • +6 more
May 15, 2023

Among Pediatric Brain Tumor and Blood Cancer Patients

Recruiting
  • Brain Tumor, Pediatric
  • Blood Cancer
  • Neurocognitive tools
  • Karachi, Sindh, Pakistan
    Nida Zahid
Jan 30, 2023

Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • Palliative Care
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

Not yet recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • (no location specified)
    Jan 11, 2023

    Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)

    Completed
    Has Results
    • Hematologic Malignancy
    • +2 more
    • Positive Psychology Intervention
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Nov 14, 2022

    Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

    Terminated
    Has Results
    • Non-Hodgkin's B-cell Lymphoma
    • +5 more
    • MT-3724 Phase 1
    • MT-3724 Phase 2
    • Tucson, Arizona
    • +40 more
    Jul 18, 2022

    Toxicity inHaematological Malignancy Treated With Immunotherapy.

    Recruiting
    • Blood Cancer
    • Data collection
    • Paris, Ile De France, France
      Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
    Jul 5, 2022

    Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

    Recruiting
    • Chronic Graft-versus-Host-Disease
    • +4 more
      • San Francisco, California
      • +15 more
      Jun 17, 2022

      CNS Infections, CNS Complication, Infectious Disease of Nervous System Trial in Worldwide

      Recruiting
      • Central Nervous System Infections
      • +5 more
        • Westmead, Australia
        • +16 more
        Jun 1, 2022

        Blood Cancer Trial (KCAT19 T cells)

        Not yet recruiting
        • Blood Cancer
        • KCAT19 T cells
        • (no location specified)
        May 20, 2022

        The Leukemia and Lymphoma Society National Research Registry

        Recruiting
        • Blood Cancer
        • any/all treatments for blood cancer
        • Rye Brook, New York
          Lymphoma and Leukemia Society
        Apr 5, 2022

        Better Leukemia Diagnostics Through AI (BELUGA)

        Recruiting
        • Hematologic Malignancy
        • +4 more
        • Automated AI-Guided Diagnosis of Hematological Malignancies
        • Munich, Bavaria, Germany
          MLL Munich Leukemia Laboratory
        Apr 4, 2022

        Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))

        Recruiting
        • Leukemia
        • +5 more
        • Bone Marrow Transplant (BMT)
        • Baltimore, Maryland
          Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
        Feb 14, 2022

        Leukemia, Lymphoma, Multiple Myeloma Trial in Calgary (Early palliative and supportive care)

        Not yet recruiting
        • Leukemia
        • +4 more
        • Early palliative and supportive care
        • Calgary, Alberta, Canada
          Tom Baker Cancer Centre
        Dec 29, 2021

        Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)

        Recruiting
        • Hematologic Malignancy
        • +2 more
        • Positive Psychology Intervention
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Dec 20, 2021

        IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)

        Recruiting
        • IDH Mutation
        • +4 more
        • Chicago, Illinois
          University of Chicago Medical Center
        Nov 12, 2021

        Blood Cancer Trial (Psychoeducation)

        Withdrawn
        • Blood Cancer
        • Psychoeducation
        • (no location specified)
        Jul 14, 2021

        COVID-19, Sars-CoV2, Cancer Trial in Augusta, Columbus (TL-895)

        Completed
        • COVID-19
        • +5 more
        • Augusta, Georgia
        • +1 more
        May 10, 2021

        Haematological Malignancy, Leukemia, Acute, Lymphoma Trial in Kuala Lumpur (WHODAS 2.0 Questionnaire)

        Completed
        • Haematological Malignancy
        • +5 more
        • WHODAS 2.0 Questionnaire
        • Kuala Lumpur, Wilayah Persekutuan, Malaysia
          University Malaya
        Nov 2, 2020

        Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

        Completed
        Has Results
        • Blood Cancer
        • +7 more
        • non-myeloablative hematopoietic cell transplantation
        • +8 more
        • Stanford, California
          Stanford University School of Medicine
        Nov 17, 2019

        Blood Cancer, Advanced B Cell Malignancies Trial in Fukuoka-shi, Isehara-shi, Nagoya-shi (MEDI-551)

        Completed
        Has Results
        • Blood Cancer
        • Advanced B Cell Malignancies
        • Fukuoka-shi, Japan
        • +2 more
        May 8, 2017

        Myeloproliferative Disorders, Blood Cancer, MDS Trial in Stanford (Total Lymphoid Irradiation (TLI), Anti-Thymocyte Globulin as

        Completed
        • Myeloproliferative Disorders
        • +2 more
        • Total Lymphoid Irradiation (TLI)
        • Anti-Thymocyte Globulin as Conditioning (ATG)
        • Stanford, California
          Stanford University School of Medicine
        Mar 16, 2015

        Blood Cancer, Breast Cancer, Prostatic Tumors Trial in Stanford, London (Cancer: Thriving and Surviving Online Workshop)

        Completed
        • Blood Cancer
        • +4 more
        • Cancer: Thriving and Surviving Online Workshop
        • Stanford, California
        • +1 more
        Feb 5, 2013